YIHAO LI

Dr. YIHAO LI


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022
Verified
Book Chapter
Closed access
PDF file
YLYIHAO LI
YIHAO LI
MDMostafa El Habib Daho
Mostafa El Habib Daho
PCPierre-Henri Conze
Pierre-Henri Conze
HHHassan Al Hajj
Hassan Al Hajj
SBSophie Bonnin
Sophie Bonnin
GQGwenolé Quellec
Gwenolé Quellec

16 September 2023
Verified
Book Chapter
Closed access
PDF file
MDMostafa EL HABIB DAHO
Mostafa EL HABIB DAHO
YLYIHAO LI
YIHAO LI
RZRachid Zeghlache
Rachid Zeghlache
YAYapo Cedric Atse
Yapo Cedric Atse
HBHugo Le Boité
Hugo Le Boité
GQGwenolé Quellec
Gwenolé Quellec

26 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
YLYIHAO LI
YIHAO LI
MDMostafa EL HABIB DAHO
Mostafa EL HABIB DAHO
PCPierre-Henri Conze
Pierre-Henri Conze
RZRachid Zeghlache
Rachid Zeghlache
HBHugo Le Boité
Hugo Le Boité
GQGwenolé Quellec
Gwenolé Quellec
Optical coherence tomography angiography (OCTA) can deliver enhanced diagnosis for diabetic retinopathy (DR). This study evaluated a deep learning (DL) algorithm for automatic DR severity assessment using high-resolution and ultra-widefield (UWF) OCTA. Diabetic patients were examined with 6×6 mm2 high-resolution OCTA and 15×15 mm2 UWF-OCTA using PLEX®Elite 9000. A novel DL algorithm was trained for automatic DR severity inference using both OCTA acquisitions. The algorithm employed a unique hybrid fusion framework, integrating structural and flow information from both acquisitions. It was trained on data from 875 eyes of 444 patients. Tested on 53 patients (97 eyes), the algorithm achieved a good area under the receiver operating characteristic curve (AUC) for detecting DR (0.8868), moderate non-proliferative DR (0.8276), severe non-proliferative DR (0.8376), and proliferative/treated DR (0.9070). These results significantly outperformed detection with the 6×6 mm2 (AUC = 0.8462, 0.7793, 0.7889, and 0.8104, respectively) or 15×15 mm2 (AUC = 0.8251, 0.7745, 0.7967, and 0.8786, respectively) acquisitions alone. Thus, combining high-resolution and UWF-OCTA acquisitions holds the potential for improved early and late-stage DR detection, offering a foundation for enhancing DR management and a clear path for future works involving expanded datasets and integrating additional imaging modalities.

30 May 2023
Verified
Book Chapter
Closed access
PDF file
YLYIHAO LI
YIHAO LI
RZRachid Zeghlache
Rachid Zeghlache
IBIkram Brahim
Ikram Brahim
HXHui Xu
Hui Xu
YTYubo Tan
Yubo Tan
MDMostafa EL HABIB DAHO
Mostafa EL HABIB DAHO

21 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
YLYIHAO LI
YIHAO LI
RZRachid Zeghlache
Rachid Zeghlache
IBIkram Brahim
Ikram Brahim
HXHui Xu
Hui Xu
YTYubo Tan
Yubo Tan
MDMostafa EL HABIB DAHO
Mostafa EL HABIB DAHO
Diabetic Retinopathy (DR) is a severe complication of diabetes that can cause blindness. Although effective treatments exist (notably laser) to slow the progression of the disease and prevent blindness, the best treatment remains prevention through regular check-ups (at least once a year) with an ophthalmologist. Optical Coherence Tomography Angiography (OCTA) allows for the visualization of the retinal vascularization, and the choroid at the microvascular level in great detail. This allows doctors to diagnose DR with more precision. In recent years, algorithms for DR diagnosis have emerged along with the development of deep learning and the improvement of computer hardware. However, these usually focus on retina photography. There are no current methods that can automatically analyze DR using Ultra-Wide OCTA (UW-OCTA). The Diabetic Retinopathy Analysis Challenge 2022 (DRAC22) provides a standardized UW-OCTA dataset to train and test the effectiveness of various algorithms on three tasks: lesions segmentation, quality assessment, and DR grading. In this paper, we will present our solutions for the three tasks of the DRAC22 challenge. The obtained results are promising and have allowed us to position ourselves in the TOP 5 of the segmentation task, the TOP 4 of the quality assessment task, and the TOP 3 of the DR grading task. The code is available at \url{https://github.com/Mostafa-EHD/Diabetic_Retinopathy_OCTA}.